Skip to content
Putting patients first: Retail pharmacies—and the patients they serve—are being endangered by PBM Power
This is the fourth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the […]
Latest News
Putting patients first: Separating PBM compensation from prices Is critical in reducing patient financial burden
This is the third in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
BIO IP conference promotes protection of innovation
Pictured above, Rep. Deborah Ross (D-NC) addresses the opening session of BIO’s Intellectual Property Counsels Committee Conference in Washington, D.C., on Nov. 18. The
BIO IP conference promotes protection of innovation Read More »
The importance of caregivers in clinical trial diversity
Over 75% of clinical trial participants in the U.S. are white. This historical statistic has held true even today, even though the American population
The importance of caregivers in clinical trial diversity Read More »
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care
This is the second in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care Read More »
Putting patients first: Why PBM reform must ensure that middlemen pass along 100% of rebates
This is the first in a series of Bio.News articles looking at the need for pharmacy benefit manager (PBM) reform through the lens of
APHIS exempts more types of biotech plants from regulation
The U.S. Department of Agriculture (USDA) on Nov. 12 announced that biotech plants made through modifications that could have been achieved by conventional breeding can be
APHIS exempts more types of biotech plants from regulation Read More »
How clinical trial diversity is the path to health equity
“We are seeing an ongoing lack of participation by diverse groups in trials,” said Wayne Frederick, M.D., MBA, President Emeritus of Howard University and
How clinical trial diversity is the path to health equity Read More »
BIO Clinical Trial Diversity Summit explores advancing equity in clinical research
On November 19, the Biotechnology Innovation Organization (BIO) Clinical Trial Diversity Summit brought together a dynamic mix of researchers, industry leaders, policymakers, and community
BIO Clinical Trial Diversity Summit explores advancing equity in clinical research Read More »
How utilization management blocks patient access
Insurers and pharmacy benefit managers (PBMs) in search of profits are preventing patients from getting the drugs they need, according to the latest episode
How utilization management blocks patient access Read More »